Kinnate Biopharma Buy Hold or Sell Recommendation
| KNTEDelisted Stock | USD 2.96 0.27 8.36% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Kinnate Biopharma is 'Not Rated'. Macroaxis provides Kinnate Biopharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KNTE positions.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. Note, we conduct extensive research on individual companies such as Kinnate and provide practical buy, sell, or hold advice based on investors' constraints. Kinnate Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Kinnate |
Execute Kinnate Biopharma Buy or Sell Advice
The Kinnate recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kinnate Biopharma. Macroaxis does not own or have any residual interests in Kinnate Biopharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kinnate Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Kinnate Biopharma Trading Alerts and Improvement Suggestions
| Kinnate Biopharma is not yet fully synchronised with the market data | |
| Kinnate Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (112.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kinnate Biopharma currently holds about 262.42 M in cash with (100.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.94, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 83.0% of the company shares are owned by institutional investors |
Kinnate Biopharma current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Kinnate analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Kinnate analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Kinnate Biopharma Returns Distribution Density
The distribution of Kinnate Biopharma's historical returns is an attempt to chart the uncertainty of Kinnate Biopharma's future price movements. The chart of the probability distribution of Kinnate Biopharma daily returns describes the distribution of returns around its average expected value. We use Kinnate Biopharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Kinnate Biopharma returns is essential to provide solid investment advice for Kinnate Biopharma.
| Mean Return | -0.03 | Value At Risk | -9.14 | Potential Upside | 8.70 | Standard Deviation | 5.59 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Kinnate Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Payment of 541 shares by Williams Richard Thomas of Kinnate BiopharmaInc subject to Rule 16b-3 [view details]
Kinnate Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kinnate . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Kinnate Biopharma Buy or Sell Advice
When is the right time to buy or sell Kinnate Biopharma? Buying financial instruments such as Kinnate Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Kinnate Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Moderate Funds Thematic Idea Now
Moderate Funds
Funds or Etfs that combine stocks, bonds and money market instruments to get modest capital appreciation over time. The Moderate Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Moderate Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Kinnate Stock
If you are still planning to invest in Kinnate Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kinnate Biopharma's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |